Dr Reddy’s Laboratories is reportedly planning to invest Rs 1,000 crore for capacity expansion during the next financial year. The proposed investment would cover expansion of the existing facilities as well as some greenfield projects.
Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.
